Draft Guidance for Industry and Staff; Availability: Factors To Consider When Making Benefit-Risk Determinations in Medical Device Premarket Review
Title: Novartis comments FDA-2010-D-0577
Novartis - Comment
This is comment on Notice
Draft Guidance for Industry and Staff; Availability: Factors To Consider When Making Benefit-Risk Determinations in Medical Device Premarket Review
View Comment
Attachments:
Novartis comments FDA-2010-D-0577
Title:
Novartis comments FDA-2010-D-0577
Related Comments
View AllPublic Submission Posted: 09/27/2011 ID: FDA-2011-D-0577-0003
Nov 14,2011 11:59 PM ET
Public Submission Posted: 11/04/2011 ID: FDA-2011-D-0577-0004
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/16/2011 ID: FDA-2011-D-0577-0005
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/16/2011 ID: FDA-2011-D-0577-0006
Nov 14,2011 11:59 PM ET
Public Submission Posted: 12/16/2011 ID: FDA-2011-D-0577-0007
Nov 14,2011 11:59 PM ET